Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer

Clinical trial NCT02410603 · COMPLETED

Trial details

NCT number: NCT02410603
Sponsor: Mayo Clinic
Status: COMPLETED
Study type: OBSERVATIONAL

Lung Cancer Lung Neoplasms Cancer of Lung Cancer of the Lung Neoplasms, Lung Neoplasms, Pulmonary Pulmonary Cancer Pulmonary Neoplasms Carcinoma, Non-small-cell Lung Adenocarcinoma Squamous Cell Carcinoma

Start date: 2016-12-01
Primary completion: 2021-01-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.